Shapes of MHC Restriction  by Garboczi, David N & Biddison, William E
Immunity, Vol. 10, 1±7, January, 1999, Copyright 1999 by Cell Press
Shapes of MHC Restriction Review
structures of a TCR b subunit and a Va domain con-David N. Garboczi*³ and William E. Biddison²³
firmed predictions that the TCR V and C domains are*Structural Biology Section
very similar to the corresponding structures observedNational Institute of Allergy and Infectious Diseases
in antibody molecules (Bentley and Mariuzza, 1996).National Institutes of Health
Each of the three CDR loops protrude from the sameRockville, Maryland 20852±1727
face of the molecule. A fourth loop, termed HV4, is also²Molecular Immunology Section
present. The exception to these similarities has beenNeuroimmunology Branch
the C domain of the a chain that has a noncanonicalNational Institute of Neurological Disorders
fold (Garcia et al., 1996; Ding et al., 1998). Structuraland Stroke
studies of entire abTCR molecules were slowed by theNational Institutes of Health
the inability to produce sufficient amounts of TCR pro-Bethesda, Maryland 20892
tein to analyze, but in the last three years, several X-ray
structures of human and murine abTCRs complexed
with peptides bound to MHC class I molecules haveThe defining component of antigen-specific recognition
been determined. Two different human abTCRs wereby T lymphocytes with ab T cell receptors (TCRs) is
identified in CD81 cytotoxic T cell clones (A6 and B7)MHC restriction. The concept of MHC restriction was
specific for the Tax 11±19 peptide (LLFGYPVYV) of hu-derived from experiments which showed that virus-spe-
man T cell lymphotrophic virus type-1 (HTLV-I) pre-cific effector T cells could only lyse virus-infected target
sented by HLA-A2 and were isolated from the peripheralcells that were of the same MHC haplotype as the ef-
blood of HTLV-I-infected patients (Utz et al., 1996). Thefector T cells (Zinkernagel and Doherty, 1974). Two mod-
A6 and B7 a and b chains were individually expressedels were proposed to explain the mechanism by which
in bacteria, then refolded and bound to soluble formsan uncharacterized TCR could be specific for both the
of HLA-A2 complexed with the Tax peptide and crystal-foreign antigen (e.g., virus) and self-MHC molecules: (1)
lized (Garboczi et al., 1996a, 1996b; Ding et al., 1998).ªaltered self,º in which a given MHC molecule was al-
A murine abTCR was obtained from a CD81 cytotoxictered in an undefined, specific way that could be recog-
T cell clone (2C) that was derived from alloimmunizationnized by a single TCR; and (2) ªdual recognition,º in
of H-2b mice with H-2d cells and was initially shown to
which two distinct receptors independently recognized
be specific for H-2Ld (Kranz et al., 1984). The 2C TCR
the foreign antigen and the self-MHC molecule. Two was subsequently shown to be able to recognize the
subsequent discoveries favored the altered self hypoth- self-peptide dEV8 (EQYKFYSV) derived from a mito-
esis. First, MHC molecules were found to be peptide- chondrial protein presented by H-2Kb (Tallquist et al.,
binding molecules; each MHC molecule specifically 1996). The a and b chains of 2C were expressed together
binds a restricted set of peptides derived from foreign in Drosophila melanogaster cells and were crystallized
and self-proteins and presents them on cell surfaces to T alone and complexed with soluble dEV8/H-2Kb com-
cells (Townsend et al., 1985; Falk et al., 1991). Moreover, plexes (Garcia et al., 1996, 1998). Another murine abTCR
structural studies of peptide/MHC complexes showed was obtained by a different group from a CD81 cytotoxic
that the surface of each complex was composed of T cell clone (N15) that was derived from mice immunized
MHC elements and amino acid side chains of the bound with vesicular stomatitis virus (VSV) and shown to recog-
peptide that protruded upward out of the MHC molecule nize the VSV8 peptide (RGYVYQGL) presented by H-2Kb
binding site where they could be contacted by a TCR (Shibata et al., 1992). The a and b chains of N15 were
(Fremont et al., 1992; Madden et al., 1993; Stern et al., expressed together in Chinese hamster ovary cells (Liu
1994). Second, the TCR responsible for specificity for et al., 1996) and crystallized with and without the soluble
both the foreign antigen and MHC was shown to be a VSV8/H-2Kb complexes. Although the N15 TCR structure
single cell surface heterodimeric protein composed of is determined to 2.8 AÊ resolution (Wang et al., 1998), the
report of the N15/H-2Kb structure is of low resolutiona and b chains (Hedrick et al., 1984; Yanagi et al., 1984;
(Teng et al., 1998).Yague et al., 1985; Dembic et al., 1986). The question
posed by these discoveries was this: how does a single
Orientation of abTCRs on theabTCR embody specificity for both foreign (and self-)
Peptide/MHC Complexpeptides plus the MHC? The most direct way to answer
Each of the Tax peptide±specific TCRs (A6 and B7) andthis question was to determine the protein structure of
the 2C TCR bind to the peptide/MHC complexes in athe TCR bound to a peptide/MHC complex.
diagonal orientation. A similar mode of binding was ob-The abTCR is similar to an antibody Fab fragment in
served in the N15 TCR/H-2Kb complex. The TCRs bindthat it consists of two disulfide-linked chains, a and b,
diagonally between the high points on the a1a2 heliceseach containing a variable (V) and constant (C) domain.
of the MHC molecule (Figure 1). It appears that thisEach variable domain has three complementarity-deter-
alignment of TCR and MHC is necessary in order for themining regions (CDR1, CDR2, CDR3), with the highest
TCR to interact with the relatively small area of peptidesequence diversity occuring in the CDR3 region (re-
surface that is not buried in the MHC molecule (Garbocziviewed in Davis et al., 1998). The first three-dimensional
et al., 1996b; Ding et al., 1998). Bound to the MHC mole-
cule in this way, the CDR1 loop of the a chain is posi-
tioned over the N-terminal end of the peptide, and the³ E-mail: web@helix.nih.gov and dgarboczi@atlas.niaid.nih.gov.
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central peptide side chain that protrudes out of the MHC
binding site. This feature of TCR recognition suggests
that peptide side chains that are protruding from the
middle of the MHC groove will be most important for
TCR recognition. Second, it places the germline-encoded
CDR2 loops over each of the MHC a helices, which
provides a docking mechanism that will not be disrupted
by the somatic diversification mechanisms that contrib-
ute to CDR3 diversity. In each of the three TCR/peptide/
MHC complexes (A6, B7, and 2C), multiple atomic con-
tacts exist between amino acid residues in the CDR2a
or CDR2b loops and conserved amino acid residues on
the a1 and a2 helices of the MHC. Since the CDR2a
and CDR2b segments from different Va and Vb genes
have conserved amino acid motifs (Arden, 1998), it is
possible that conserved CDR2 motifs provide a com-
monality which permits different V region CDR2s to bind
to any class I molecule that displays its own conserved
residues on the a1 and a2 helices. Such a conserved
docking structure could provide an explanation for the
difficulty in inducing MHC-restricted antibodies. While
antibody CDR3 loops could bind to the peptide side
chains that point up out of the MHC molecule, antibodies
do not have the conserved sequence motifs of the CDR2
Figure 1. Side View of the Four Known TCR/MHC Orientations loops of TCR V segments and may thus have difficulty
Ribbon depiction of the human A6 and B7 and the mouse 2C and docking onto the MHC molecule.
N15 TCRVaVb regions oriented on their respective MHC complexes. To date, a structure has not been reported of the
The VaVb domains are shown in red (Va) and in green (Vb). In blue
complex of a TCR and a peptide/MHC class II molecule,are the helices (front, a2; back, a1) of the MHC molecules. In gray
so it is not yet known if this diagonal mode of TCRis the b sheet forming the floor of the MHC peptide-binding site. This
figure was made by superimposing (program LSQMAN [Kleywegt, interaction with peptide/MHC class I molecules will be
1996]) each MHC a1a2 domain on to the a1a2 domain of HLA- applicable to class II interactions. However, studies on
A2 using coordinates deposited at the Protein Data Bank (PDB) class II±restricted TCR recognition using TCR mutagen-
(accession numbers 1ao7, 1bd2, and 2ckb) and from J.-H. Wang esis (Engel and Hedrick, 1988; Katayama et al., 1995)
(Teng et al., 1998) and by depicting the orientations with the program
and TCR selection by variant peptide immunization (Jor-MOLSCRIPT (Kraulis, 1991). Not shown are the constant domains
gensen et al., 1992; Sant'Angelo et al., 1996) all provideof the TCR and the a3 and b2m domains of the MHC molecule.
indirect evidence that the use of such a diagonal binding
mode will also be true for class II±restricted TCR recog-
CDR1 loop of the b chain is over the C-terminal end of nition.
the peptide. The CDR2 loop of the a chain is positioned
over the MHC a2 helix, and the CDR2 of the b chain lies
over the MHC a1 helix. The CDR3 loops of both a and TCR Interactions with Peptides
In theory, the TCR could interact with any part of anb chains combine to form a central pocket that can bind
a peptide residue that extends from the surface of the MHC-bound peptide that is not buried in the MHC mole-
cule; moreover, specificity of the TCR for total peptideMHC molecule. This diagonal orientation has two impor-
tant consequences for TCR recognition. First, it places binding could be a sum of specific interactions with
many peptide side chains. However, this hypothesis wasthe part of the TCR with the most extensive sequence
diversity (CDR3s) directly over the center of the MHC/ not borne out by the data (see Table 1). Most of the TCR
contacts with peptide involve only one or two peptidepeptide complex, which permits direct binding to any
Table 1. Contacts between Residues of the Tax and dEV8 Peptides and Their TCRs
Tax P1 P2 P3 P4 P5 P6 P7 P8 P9
Peptide L L F G Y P V Y V Total
A6 TCR 1 1 0 9 18 3 5 12 0 49
B7 TCR 2 0 0 6 26 1 8 13 0 56
dEV8 P1 P2 P3 P4 P5 P6 P7 P8
Peptide E Q Y K F Y S V Total
2C TCR 0 0 0 19 0 5 4 0 28
Atoms of peptide and TCR amino acid residues that are less than 4 AÊ apart were listed by the program CONTACT (CCP4, 1994) using TCR/
peptide/MHC coordinate files (legend to Figure 1) as input and tabulated here. For example, for the P5 tyrosine of the Tax peptide there are
18 atom±atom pairs in which an atom of the tyrosine residue (main chain or side chain) and an atom of the A6 TCR are positioned less than
4 AÊ apart.
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amino acids. The A6 and B7 TCRs contact similar amino
acid side chains of the Tax peptide (Table 1, see legend
for definition of contact). Both receptors have the major-
ity of their contacts with the tyrosine residue at position
5 (P5) of the peptide, binding the side chain in the central
cavity formed by the CDR3a and CDR3b loops (see
Figure 3, below). Both Tax peptide±specific TCRs focus
almost exclusively on two amino acid side chains (P5Y
and P8Y) that protrude from the HLA-A2 peptide binding
groove. The conformation of the bound Tax peptide is
essentially the same in both the A6 and B7 TCR/peptide/
MHC complexes. Comparison of the structure of the
Tax peptide as determined in the complex with soluble
HLA-A2 without the TCR (Madden et al., 1993) shows
that both the A6 and B7 TCRs substantially deform the
P6 and P7 residues of the peptide (Garboczi et al.,
1996b; Ding et al., 1998).
In contrast, the 2C TCR forms many fewer atomic
contacts with the dEV8 peptide (Table 1). The large cen-
tral cavity of the 2C TCR formed by the CDR3a and
CDR3b loops is not occupied by a peptide side chain.
The majority of the atomic contacts are with the upward-
pointing P4 Lys. In addition, the interface of the 2C TCR
with the dEV8 peptide shows a rather low degree of
complementarity and quite distal peptide contacts (Gar-
cia et al., 1998). Together, these properties of the 2C
TCR dEV8/Kb interface may explain the relatively weak
affinity of this particular interaction (KD z 8 3 1025 M
[Garcia et al., 1997]) as well as the ability of self-Kb
molecules to positively select the 2C TCR in TCR
transgenic mice (Sha et al., 1988). If the 2C TCR/dEV8/
H-2Kb interaction is typical of TCR/selecting self-peptide
interactions in general, then positive selection will occur
only if the TCR has a similar ªpoor fitº to the endogenous
peptide/MHC complex that it encounters during thymic
selection. A ªbetter fitº interaction, as typified by A6 or
B7 TCRs with the Tax/HLA-A2 complex, could then lead
to negative selection. Figure 2. Conserved and Variable MHC Residues Contacted by TCRs
The observation that all three TCRs focus on only
Ribbon diagrams of class I molecules show the location of MHC
a few peptide amino acids also helps to explain the amino acids that are contacted (within 4 AÊ ) by the A6, B7, or 2C
phenomenon of altered peptide ligands (APLs). APLs TCRs and are either conserved (red circles) or are variable (yellow
were originally defined as agonist peptides with single circles) in HLA-A alleles or in H-2K alleles (also see Table 2). The
a1 helix is at the top and the a2 helix is at the bottom. N, aminoamino acid substitutions that altered T cell respon-
terminus of MHC heavy chain. The disulfide bond between residuessiveness (reviewed in Sloan-Lancaster and Allen, 1996).
101 and 164 is shown.Certain amino acid substitutions produced partial ago-
nists that were able to stimulate some, but not all, of
the T cell responses induced by the agonist ligand. Other
agonist response for clone A6 (Garboczi et al., 1996a).amino acid substitutions produced antagonists that
It can be seen (Table 1) that such a substitution changedcould induce downregulation of responses to the ago-
the amino acid that made the most contacts to the Taxnist peptide. The partial agonist and antagonist patterns
peptide by the A6 TCR.of T cell responsiveness were accompanied by differen-
tial signal transduction as revealed by the phosphoryla-
TCR Interactions with MHC Moleculestion patterns of the TCR-associated z chains and ZAP-
One question that arises from these studies is this: since70 (Sloan-Lancaster et al., 1994; Madrenas et al., 1995).
the TCR focuses on just a few of the peptide aminoPartial agonist and antagonist peptide/MHC complexes
acids, is it also true that the TCR focuses on only a fewwere shown to bind to TCRs with a lower affinity than
amino acids on the MHC molecule? The answer appearsthe agonist complexes (reviewed in Davis et al., 1998).
to be no, since each of the three TCRs has multipleThe structural data from the three TCR/peptide/MHC
contacts with MHC amino acid residues on the a1 andcomplexes described above suggests that this APL ef-
a2 helices (Figure 2). The majority of the contacts arefect is a consequence of peptide substitutions that dis-
with conserved amino acids in each MHC allele (Figure 2;rupt some of the contacts with the TCR and reduce
Table 2). For example, the 2C TCR contacts two variablebinding to the one or two amino acids that comprise
amino acids but binds to 13 conserved residues on thethe most contacts with the peptide. For example, substi-
tution of the P5 Tyr of Tax with Ala induces a partial Kb molecule (Figure 2). Thus, for each of the three TCR/
Immunity
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Table 2. Contacts between MHC Residues and TCR a and b Subunits
A6 A6 B7 B7
a b a b
HLA-A2
HLA-A HLA-B HLA-C Residue M S M S M S M S
E E E 58E 0 9
Y YH Y 59Y 1 0
GRQEL GR R 62G 1 0
RG RQ Q 65R 0 13 0 14 0 1
KN INK KN 66K 0 6
K K KN 68K 1 0
A TAR R 69A 1 3 0 1
Q Q Q 72Q 0 1 0 1
AT A A 149A 2 0
AV A A 150A 14 3 1 1
HR R R 151H 0 1
Q Q QE 155Q 0 1 0 5 0 1 0 1
AV AT A 158A 0 1 7 4
Y Y Y 159Y 0 1
G GD G 162G 2 0
TREL TLE TLE 163T 0 2 0 1
ED ED E 166E 0 7
WG WGS W 167W 0 3 0 3
R R RG 170R 0 4
2 50 16 10 11 24 1 4
52 26 35 5
HLA-A2 residues (i.e., 58E, 59Y, 62G, . . . ) are those contacted (,4 AÊ ) by either the A6 or B7 TCRs. Residues found in other HLA-A, -B, and -C
alleles are shown (Kostyu et al., 1997). Columns headed by ªMº or ªSº list the number of contacts from a TCR subunit to main chain or side
chain MHC atoms, respectively. Contacts were identified as described in the legend to Table 1.
MHC interfaces described thus far, the predominant in- dual recognition model except that a single receptor is
utilized to separately recognize foreign and self-anti-teractions are with multiple conserved amino acids on
the a1 and a2 helices of the MHC. These findings sug- gens. These findings refute one of the extreme versions
of the altered self model, which postulated that no rec-gest that conserved MHC residues play a critical role in
TCR interactions and implies that TCRs were evolution- ognition of a foreign component by TCRs occurred, but
only a conformationally altered self-MHC molecule thatarily selected for their ability to recognize conserved
features of MHC molecules (Janeway et al., 1997; Zer- resulted from binding of the foreign element.
rahn et al., 1997). Knowing the relative energetic contri-
butions of each contact will require mutagenesis and Comparison of A6 and B7 TCR/Tax
Peptide/HLA-A2 Complexesquantitative binding studies.
The TCR a chain mediates most of the contacts with Just as the A6 and B7 Tax-specific T cells recognize
the same MHC molecule through structurally distinctthe MHC molecule (Table 2, for 2C, data not shown).
The A6 and B7 a subunits show more interactions with interactions, these two T cells also recognize the Tax
peptide differently. This conclusion was derived fromthe side chain atoms of HLA-A2 than with main chain
atoms, especially with the Arg side chain at position 65 studies which showed that A6 and B7 differentially rec-
ognized Tax peptides with single amino acid substitu-(65R) of the a1 helix (Table 2). In the A6 b chain, contacts
are about evenly divided between MHC main and side tions at TCR contact residues (Ding et al., 1998). By
comparing how these TCRs bind the same peptide/chain atoms, with a principal focus on the main chain
atoms of the Ala at position 150 (150A). In contrast, MHC, we could address the question of how two differ-
ent T cell receptors recognize the same peptide/MHCthe B7 b chain makes very few contacts with the MHC
molecule. Thus, these two different TCRs recognize the in different ways. The most remarkable feature revealed
by a comparison of these two structures is that onlysame MHC molecule through structurally distinct inter-
actions. These findings imply that multiple solutions ex- one of the 17 TCR amino acids in B7 that contact the
peptide/MHC complex is shared with the A6 TCRist for the problem of MHC-restricted TCR recognition
of a particular MHC molecule and also indicate the pres- (CDR2a51S). This amino acid diversity produces signifi-
cantly different molecular contact surfaces on the A6ence of extensive diversity in the capacity of TCRs to
effectively bind MHC molecules once they have achieved versus B7 TCRs (Figure 3). Most notable is the central
cavity of each TCR, which binds the P5 Tyr of the Taxthe diagonal binding orientation.
Now that we have observed the diverse mechanisms peptide (Figure 3). This cavity is positively charged in
A6 (blue in Figure 3) and negatively charged and smallerby which these TCRs recognize their respective pep-
tides and MHC molecules, the answer to the original in B7 (red in Figure 3). These differences in the molecular
contact surfaces of the central cavity explain why aminoquestion seems clear: the TCR makes separate contacts
with distinct components of the peptide and of the MHC acid substitutions at P5 in the Tax peptide differentially
affect recognition by the A6 and B7 TCRs (Ding et al.,molecule. This solution is somewhat like the original
Review
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Structural Flexibility of the TCR
Do the CDR loops of the TCR have the ability to move
to accommodate binding to peptide and MHC compo-
nents? The structure of the 2C TCR was initially deter-
mined on an unliganded form of the receptor (Garcia et
al., 1996) and was determined again when bound to the
dEV8/Kb complex (Garcia et al., 1998). Comparison of
these two structures yielded important findings about
the structural consequences of ligand binding and the
flexibility of the contact surfaces (Garcia et al., 1998).
Although no major domain rearrangements were found
in the liganded form, large conformational adjustments
were observed in the CDRs that contacted the peptide.
This structural flexibility of the CDRs that contact pep-
tide could explain the capacity of a single TCR to accom-
modate structurally diverse peptides and thereby pro-
duce the phenomenon known as cross-reactivity or
molecular mimicry. In contrast, CDRs that were primarily
involved in contact with the MHC a helices did not move
significantly. This apparent lack of movement in the
CDRs that interact with the MHC indicates their involve-
ment in conserved interactions (Garcia et al., 1998). This
issue is particularly pertinent to the observation that
most MHC residues that are contacted by all three TCRs
are conserved (Figure 2) and provides a structural expla-
nation for the finding that the predominant TCR/MHC
interactions are with conserved elements on MHC mole-
cules.
Recent studies on TCR recognition have begun to
emphasize the importance of a significant level of cross-
reactivity on different peptides, which is necessary to
produce an adequate TCR repertoire capable of re-
sponding to the universe of pathogens (reviewed in Ma-
Figure 3. Comparison of A6 and B7 TCR Surfaces that Contact the son, 1998). Development of the TCR repertoire during
Tax Peptide
thymic selection occurs on a set of self-peptides bound
The Tax peptide is shown as a ball and stick model, and the electro-
by self-MHC molecules, but these self sequences maystatic charge potential of the TCR surfaces is shown in red for
have little or no sequence homology with pathogen-negative, blue for positive, and white for neutral. The figure is drawn
derived peptides. Also, activation of autoreactive TCRswith the program GRASP (Nicholls et al., 1991).
can occur by recognition of pathogen-derived peptides
that possess little or no primary sequence homology
1998). The direct demonstration that two TCRs with very with the selecting self-peptide (Wucherpfennig and
different contact surfaces can bind the same peptide/ Strominger, 1995; Hemmer et al., 1997). The TCR/pep-
MHC complex indicates that a diverse repertoire of tide/MHC structures determined to date indicate that
TCRs can recognize any single peptide/MHC complex. the required degree of peptide cross-reactivity can be
This feature of the TCR provides an explanation for the produced in at least two ways: (1) the TCRs focus on
diverse array of abTCRs observed in Tax peptide/HLA- only a few amino acid side chains of the peptide and
A2-specific T cell clones derived from three HTLV-1- can accommodate peptides with other side chains, de-
infected patients (Utz et al., 1996). In addition, flexibility pending on the size and surface chemistry of the TCR
in the chemistry of the contact surface of the TCR also contact surfaces; and (2) the structural flexibility of the
provides an advantage for the host immune response to CDR3 loops that contact the peptide allow a degree of
small protein antigens. Such small proteins will generate accommodation of binding to multiple peptide ligands.
relatively few peptides, only a small fraction of which Future studies of the structures of the same TCR bound
will be of the appropriate length and sequence capable to structurally diverse peptides presented by the same
of binding a particular MHC molecule with sufficient MHC molecule should provide further insights into the
affinity to produce enough complexes on the cell surface biophysical basis of TCR cross-reactivity.
to trigger TCRs. If only a very limited number of TCRs
that could bind a particular peptide/MHC complex were
available, then it is likely that there would be no response Structural Implications for TCR Signaling
The purpose of TCR ligand binding is to initiate signalto such small protein antigens. The property of having
a structurally diverse set of TCRs that can recognize transduction that results in the activation of functional
programs within the cell. How does binding of ligandthe same peptide/MHC complex in different ways ex-
pands the available repertoire for recognition of any on the extracellular V domains of the TCR translate into a
functional message inside the cell? One model to explainprotein.
Immunity
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Garboczi, D.N., Utz, U., Ghosh, P., Seth, A., Kim, J., van Tienhoven,these events is that ligand binding by the TCR V domains
A.E., Biddison, W.E., and Wiley, D.C. (1996a). Assembly, specificinduces a conformational change in the C domains that,
binding, and crystallization of a human TCR-ab with an antigenicin turn, changes the dynamics of the interactions with
Tax peptide from human T lymphotropic virus type 1 and the class
CD3 chains and/or z chains associated with the receptor I MHC molecule HLA-A2. J. Immunol. 157, 5403±5410.
and thus transduces a signal through these associated Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and
components. However, a comparison of the liganded Wiley, D.C. (1996b). Structure of the complex between human T-cell
and unliganded forms of 2C showed that the conforma- receptor, viral peptide and HLA-A2. Nature 384, 134±141.
tional changes that occurred in the TCR as a result of Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson,
M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An ab Tantigen binding did not appear to involve the constant
cell receptor structure at 2.5 AÊ and its orientation in the TCR-MHCdomains of the molecule (Garcia et al., 1998). In addition,
complex. Science 274, 209±219.comparison of the Ca-Cb interfaces of the liganded B7
Garcia, K.C., Tallquist, M.D., Pease, L.R., Brunmark, A., Scott, C.A.,TCR with unliganded 2C and N15 showed that they were
Degano, M., Stura, E.A., Peterson, P.A., Wilson, I.A., and Teyton, L.nearly identical (Ding et al., 1998). Thus, the current (1997). ab T cell receptor interactions with syngeneic and allogeneic
structural evidence does not support the conformational ligands: affinity measurements and crystallization. Proc. Natl. Acad.
change model. Sci. USA 94, 13838±13843.
An alternate model for signal transduction by the TCR Garcia, K.C., Degano, M., Pease, L.R., Huang, M., Peterson, P.A.,
postulates that ligand binding induces receptor aggre- Teyton, L., and Wilson, I.A. (1998). Structural basis of plasticity in T
cell receptor recognition of a self peptide-MHC antigen. Sciencegation and/or oligomerization that segregates the bound
279, 1166±1172.receptors into cell±cell attachment patches (Davis et
Hedrick, S.M., Cohen, D., Nielsen, E., and Davis, M. (1984). Isolational., 1998). Such receptor aggregation would facilitate
of cDNA clones encoding T cell-specific membrane-associated pro-clustering of intracellular components required for the
teins. Nature 308, 149±153.
recruitment and phosphorylation of signal transduction
Hemmer, B., Fleckenstein, B.T., Vergelli, M., Jung, G., McFarland,components. The adoption of a uniform orientation in H., Martin, R., and WiesmuÈ ller, K.-H. (1997). Identification of high
TCR binding to peptide/MHC complexes may provide potency microbial and self ligands for a human autoreactive class
a mechanism that facilitates TCR aggregation and inter- II-restricted T cell clone. J. Exp. Med. 185, 1651±1659.
actions with the coreceptors (CD3s, CD4/CD8) that can Janeway, C.A., Jr., Chervonsky, A.V., and Sant'Angelo, D. (1997).
T-cell receptors: is the repertoire inherently MHC-specific? Curr.generate a T cell signal (Davis et al., 1998). At this junc-
Biol. 7, R299±R300.ture, no evidence for dimerization or oligomerization of
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